Global Home Global Home
UNITED STATES

 

A New Era in Anti-Infectives

 

Latest News
..........................................

May 11th, 2012
Oculus Innovative Sciences Prepares to Initiate Clinical Study for Use of Microcyn(R) Hydrogel in Management of Scars Based Upon FDA-Reviewed Protocol

May 9th, 2012
Oculus Innovative Sciences Microcyn(R) Technology to be Showcased at the Columbia University 10th Annual Innovations in Complex Vascular & Endovascular Interventions in New York City on May 10-11, 2012

April 26th, 2012
Oculus Innovative Sciences' Microcyn Acute Care Products Showcased at Symposium on Advanced Wound Care in Atlanta

April 23rd, 2012
Oculus Innovative Sciences, Inc. to Raise $3.1 Million in Registered Direct Offering

March 23rd, 2012
Oculus Innovative Sciences Provides Business Update From Roth Capital 23rd Annual Growth Conference

March 6th, 2012
Oculus Innovative Sciences Partner, Eloquest Healthcare, Launches Microcyn(R) Wound Care Products Into U.S. Hospitals, Ambulatory Surgical and Acute Care Centers

February 21st, 2012
Oculus Innovative Sciences Partner, Quinnova Pharmaceuticals, Launches Microcyn(R)-Based Atrapro(TM) Products

February 2nd, 2012
Oculus Innovative Sciences Reports Fiscal Third Quarter 2012 Financial Results

January 19th, 2012
Oculus Innovative Sciences Announces Fiscal Third Quarter 2012 Financial Results and Conference Call

December 29th, 2011
Oculus Innovative Sciences to Present at Biotech Showcase 2012 in San Francisco

More »


About Oculus

Oculus Innovative Sciences is a commercial healthcare company that designs, produces and markets innovative, safe and effective healthcare products. Oculus is pioneering innovative solutions in multiple markets including dermatology, surgical, wound care, animal healthcare and others, and has commercialized products in the United States, Europe, India, China and Mexico and select Middle East countries. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America.